Cooley LLP, Washington, DC, USA.
Nat Biotechnol. 2011 Feb;29(2):129-33. doi: 10.1038/nbt.1765.
Strategies are needed for drafting miRNA patent applications, in light of the existing patent landscape and genomic patent strategies of the past decades.
需要制定 miRNA 专利申请策略,以应对现有专利格局和过去几十年的基因组专利策略。